The FDA has approved Auvelity as the first non-antipsychotic treatment for agitation in Alzheimer's disease, marking a major ...
An at-home, mail-in, finger-stick blood test detected Alzheimer’s-related biomarkers associated with cognitive performance in ...
In a study published in Neurochemistry International, researchers found that arginine reduced the buildup of toxic amyloid β ...
A newly published study shows that while disease-modifying therapies (DMTs) may offer substantially greater health benefits ...
Eli Lilly launches Alzheimer’s drug Lormalzi in India, offering early-stage treatment amid growing scientific debate over its ...
Health and Me on MSN
India gets its first Alzheimer’s drug: Know all about Eli Lilly’s Lormalzi
The once-monthly therapy, administered as an intravenous infusion, targets amyloid plaques in the brain and may help slow ...
Cochrane review says amyloid-targeting Alzheimer's drugs are ineffective, but the Alzheimer's Association and drug makers ...
Doctors and patients are gaining an edge in the fight against Alzheimer’s disease by catching early warning signs with new screening methods.
A novel approach using a lysosomal enzyme to prevent and reverse amyloid accumulation inside as well as outside neurons, with greater potency, delivered in a one-time gene therapy ...
Findings suggest that egg consumption is associated with lower Alzheimer's disease risk, supporting the need for further ...
3d
Using the body's own sounds to diagnose Alzheimer's and Parkinson's before the first symptoms appear
Long before the telltale signs of Parkinson's disease appear, including tremors and muscle stiffness, there are other, more ...
Eli Lilly launches Lormalzi in India, a once-monthly Alzheimer's therapy for mild impairment. It targets amyloid plaques to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results